Alaya.bio

About:

Polymeric delivery platform for in vivo applications

Website: https://www.alaya.bio/

Description:

Alaya.bio is a pioneering biotechnology company dedicated to advancing in situ gene delivery platform, particularly in the field of CAR T cell immunotherapy. Alaya.bio’s proprietary polymeric delivery nanoparticle offers precise targeting of cells and organs, and enhanced delivery of a wide range of therapeutic payloads, from viral vectors to nucleic acids (incl. mRNA).

Total Funding Amount:

$3M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2022-06-15

Contact Email:

hello(AT)alaya.bio

Founders:

Cécile BAUCHE, Renaud VAILLANT

Number of Employees:

11-50

Last Funding Date:

2022-08-08

IPO Status:

Private

Industries:

© 2025 bioDAO.ai